GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
Turnover
46.55%
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
-13.74%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$20.2B
AUM Growth
-$5.1B
(-20%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-7.26%
Top 10 Holdings %
Top 10 Hldgs %
39.77%
Holding
89
New
8
Increased
19
Reduced
43
Closed
11
Avg Time Held
1.2
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WestRock Company
WRK
|
+$261M |
| 2 |
Cigna
CI
|
+$258M |
| 3 |
MON
Monsanto Co
MON
|
+$240M |
| 4 |
Brookdale Senior Living
BKD
|
+$179M |
| 5 |
Agilent Technologies
A
|
+$173M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ROCK-TENN COMPANY CL-A
RKT
|
+$296M |
| 2 |
McDonald's
MCD
|
+$276M |
| 3 |
VCA Inc.
WOOF
|
+$265M |
| 4 |
Citigroup
C
|
+$227M |
| 5 |
Fidelity National Financial
FNF
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.82% |
| 2 | Industrials | 10.69% |
| 3 | Technology | 9.35% |
| 4 | Materials | 8.79% |
| 5 | Consumer Discretionary | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Humana
HUM
$51.5B
| $1.19B | 5.89% |
6,635,390
+68,423
| +1% | +$12.6M |
2013 Q2
9 quarters
|
|
|
MON
2
DELISTED
Monsanto Co
MON
| $1.15B | 5.72% |
13,502,678
+2,429,541
| +22% | +$240M |
2013 Q3
8 quarters
|
|
3
Thermo Fisher Scientific
TMO
$250B
| $1.04B | 5.16% |
8,511,204
-748,506
| -8% | -$97.5M |
2013 Q2
9 quarters
|
|
4
AbbVie
ABBV
$504B
| $880M | 4.37% |
16,170,903
-1,685,038
| -9% | -$110M |
2015 Q1
2 quarters
|
|
5
Flex
FLEX
$36.8B
| $792M | 3.93% |
99,698,783
| – | – |
2013 Q2
9 quarters
|
|
|
6
Cigna
CI
$76.3B
| $621M | 3.08% |
4,595,790
+1,774,321
| +63% | +$258M |
2013 Q2
9 quarters
|
|
7
Tenet Healthcare
THC
$21.9B
| $609M | 3.02% |
16,490,230
+1,697,917
| +11% | +$87.7M |
2013 Q2
9 quarters
|
|
|
AET
8
DELISTED
Aetna Inc
AET
| $609M | 3.02% |
5,563,508
-7,900
| -0.1% | -$913K |
2013 Q4
7 quarters
|
|
9
Elevance Health
ELV
$92.1B
| $595M | 2.95% |
4,250,401
-369,265
| -8% | -$55.5M |
2014 Q1
6 quarters
|
|
10
Labcorp
LH
$25.9B
| $528M | 2.62% |
5,663,785
+1,026,880
| +22% | +$106M |
2015 Q2
1 quarter
|
|
11
Community Health Systems
CYH
$423M
| $517M | 2.57% |
14,633,492
| – | – |
2013 Q2
9 quarters
|
|
12
ManpowerGroup
MAN
$2.4B
| $495M | 2.45% |
6,038,795
| – | – |
2015 Q1
2 quarters
|
|
|
ENDP
13
DELISTED
Endo International plc
ENDP
| $481M | 2.39% |
6,944,273
-1,893,430
| -21% | -$152M |
2014 Q1
6 quarters
|
|
14
Cadence Design Systems
CDNS
$90.6B
| $476M | 2.36% |
23,013,908
| – | – |
2014 Q2
5 quarters
|
|
15
PVH
PVH
$3.73B
| $445M | 2.21% |
4,360,523
-900,351
| -17% | -$102M |
2013 Q2
9 quarters
|
|
16
DELISTED
Paramount Global Class B
PARA
| $432M | 2.15% |
10,833,651
+2,101,936
| +24% | +$102M |
2013 Q2
9 quarters
|
|
17
HCA Healthcare
HCA
$102B
| $427M | 2.12% |
5,513,278
+334,700
| +6% | +$29.6M |
2013 Q2
9 quarters
|
|
|
18
DELISTED
VCA Inc.
WOOF
| $425M | 2.11% |
8,073,670
-4,726,700
| -37% | -$265M |
2014 Q1
6 quarters
|
|
19
Herc Holdings
HRI
$4.04B
| $422M | 2.1% |
8,414,055
+2,543,092
| +43% | +$133M |
2014 Q1
6 quarters
|
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $414M | 2.06% |
1,523,609
-459,100
| -23% | -$141M |
2014 Q3
4 quarters
|
|
21
Avis
CAR
$3.69B
| $412M | 2.04% |
9,433,220
+1,075,751
| +13% | +$46.7M |
2014 Q1
6 quarters
|
|
|
22
Brookdale Senior Living
BKD
$2.4B
| $405M | 2.01% |
17,641,415
+6,049,985
| +52% | +$179M |
2014 Q2
5 quarters
|
|
23
McKesson
MCK
$114B
| $335M | 1.66% |
1,810,249
+784,500
| +76% | +$166M |
2013 Q2
9 quarters
|
|
24
Alphabet (Google) Class C
GOOG
$4.2T
| $326M | 1.62% |
10,205,880
-445,480
| -4% | -$13.7M |
2015 Q1
2 quarters
|
|
25
DuPont de Nemours
DD
$17.2B
| $308M | 1.53% |
2,871,167
-87,817
| -3% | -$10.2M |
2014 Q3
4 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Glenview Capital Management held 89 positions worth $20.2B, down 20% from $25.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Glenview Capital Management withdrew a net $1.46B in Q3 2015, closing 11 positions and reducing 43 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $296M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 41% a quarter earlier, followed by Industrials and Technology.
Against the trend, Glenview Capital Management opened a new position in WestRock Company worth $226M.
- Glenview Capital Management's largest Q3 2015 buy was WestRock Company: 4,873,341 shares worth $226M.
- Glenview Capital Management added most to Cigna in Q3 2015, an estimated $258M increase.
- Glenview Capital Management's biggest Q3 2015 reduction was VCA Inc., cutting an estimated $265M.
- Glenview Capital Management fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $296M.
- Glenview Capital Management's ten largest holdings make up 40% of its $20.2B portfolio in Q3 2015.
- Glenview Capital Management opened 8 new positions and closed 11 in Q3 2015.
- Glenview Capital Management's portfolio value fell 20% quarter-over-quarter to $20.2B.
Based on Glenview Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.